Ignite Creation Date:
2025-12-24 @ 11:08 PM
Ignite Modification Date:
2026-01-07 @ 8:19 PM
Study NCT ID:
NCT06615869
Status:
COMPLETED
Last Update Posted:
2025-07-11
First Post:
2024-09-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate Molnupiravir Tablet Formulation Compared to the Molnupiravir Capsule Formulation in Healthy Adult Participants (MK-4482-011)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-01-20
Start Date Type:
ACTUAL
Primary Completion Date:
2023-02-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-03-15
Completion Date Type:
ACTUAL
First Submit Date:
2024-09-24
First Submit QC Date:
None
Study First Post Date:
2024-09-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-08
Last Update Post Date:
2025-07-11
Last Update Post Date Type:
ACTUAL